
TSE:CSH.UN
This summary was created by AI, based on 9 opinions in the last 12 months.
Chartwell Retirement Residences (CSH.UN-T) is positioned well within the retirement residence market, benefitting from aging demographics and a lack of new supply. Most experts are bullish on the stock, highlighting its solid fundamentals, including high occupancy rates above 95%, which are expected to improve further. Analysts agree on the company's potential for growth, noting its strategy to expand through acquisitions rather than traditional equity raises, which has generated some volatility but is largely seen as a sound long-term approach. Despite its current high price-to-earnings ratio compared to peers, many believe in its strong growth narrative and ability to maintain or increase margins over the coming years, with positive trends in earnings growth projected through 2028.
Free cashflow seems to be inflecting. Last quarter was in line. Net operating income was up and moving higher. Occupancy up. Looks to be in the midst of a turnaround. Reasonable valuation of 14.9x. Sets up well from a PEG level. Caution: because debt matters, if inflation and interest rates stay high or go higher, this may not be the best name to own. Yield is 5.96%.
(Analysts’ price target is $12.20)In very different sectors. Both trade at wide discount to NAV. Neither has catalysts on horizon. CSH.UN at risk of cutting distribution, which is not being covered due to lower occupancy. CSH trustees see growth coming, but can it recover occupancy levels lost during Covid? He's watching that, as it's hard to invest in the face of a possible cut. D.UN is in an extremely tough sector. Office space, globally, has suffered with work from home. Office sector is not dead, but vacancy rates are in high teens and climbing. A good operator, Dream still owns good office buildings, especially in Toronto.
Expecting healthcare sector to increase in demand.
Strong franchise within the company.
Earnings/cash flow estimates expected to grow at record rate.
Occupancy rates increasing after Covid-19.
Current share price at 20% to NAV - good time to buy.
Expecting a $12 share price in 2024.